Lori J. Pierce

31.9k total citations · 6 hit papers
232 papers, 14.0k citations indexed

About

Lori J. Pierce is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lori J. Pierce has authored 232 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Cancer Research, 92 papers in Oncology and 59 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lori J. Pierce's work include Breast Cancer Treatment Studies (127 papers), Advanced Radiotherapy Techniques (42 papers) and Breast Lesions and Carcinomas (37 papers). Lori J. Pierce is often cited by papers focused on Breast Cancer Treatment Studies (127 papers), Advanced Radiotherapy Techniques (42 papers) and Breast Lesions and Carcinomas (37 papers). Lori J. Pierce collaborates with scholars based in United States, Canada and Netherlands. Lori J. Pierce's co-authors include Candace R. Correa, Reshma Jagsi, Timothy J. Whelan, Sarah C. Darby, David J. Cutter, Paul McGale, Richard Gray, Marianne Ewertz, Jean M. Moran and Robin B. Marsh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Lori J. Pierce

224 papers receiving 13.6k citations

Hit Papers

Effect of radiotherapy after breast-conse... 1995 2026 2005 2015 2011 2010 1995 2010 2017 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori J. Pierce United States 55 8.2k 4.4k 3.5k 3.3k 3.1k 232 14.0k
Alain Fourquet France 62 9.5k 1.2× 5.5k 1.3× 2.2k 0.6× 2.0k 0.6× 5.6k 1.8× 374 14.0k
Harry Bartelink Netherlands 74 9.1k 1.1× 7.1k 1.6× 3.8k 1.1× 3.9k 1.2× 5.2k 1.7× 270 20.5k
Marie Overgaard Denmark 55 7.3k 0.9× 4.3k 1.0× 2.0k 0.6× 2.5k 0.8× 3.3k 1.1× 139 12.5k
John Yarnold United Kingdom 50 5.2k 0.6× 3.3k 0.8× 3.6k 1.0× 3.5k 1.1× 1.8k 0.6× 193 10.4k
Bruce G. Haffty United States 71 10.7k 1.3× 8.1k 1.9× 2.2k 0.6× 2.9k 0.9× 5.7k 1.8× 538 20.6k
Jay R. Harris United States 75 13.9k 1.7× 7.1k 1.6× 2.3k 0.7× 2.8k 0.9× 8.1k 2.6× 279 19.0k
Ivo A. Olivotto Canada 60 8.9k 1.1× 5.8k 1.3× 2.2k 0.6× 2.0k 0.6× 4.4k 1.4× 242 13.9k
Alphonse G. Taghian United States 59 7.0k 0.9× 5.2k 1.2× 2.1k 0.6× 2.0k 0.6× 3.5k 1.1× 268 11.7k
Candace R. Correa United States 16 5.0k 0.6× 2.4k 0.5× 3.1k 0.9× 2.7k 0.8× 1.5k 0.5× 24 8.7k
Melvin Deutsch United States 43 9.3k 1.1× 5.8k 1.3× 1.4k 0.4× 1.7k 0.5× 5.5k 1.8× 161 15.6k

Countries citing papers authored by Lori J. Pierce

Since Specialization
Citations

This map shows the geographic impact of Lori J. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori J. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori J. Pierce more than expected).

Fields of papers citing papers by Lori J. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori J. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori J. Pierce. The network helps show where Lori J. Pierce may publish in the future.

Co-authorship network of co-authors of Lori J. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Lori J. Pierce. A scholar is included among the top collaborators of Lori J. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori J. Pierce. Lori J. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Haidi, Denise Kendrick, Kent A. Griffith, et al.. (2024). Analysis of Patient Reported Outcomes in the Prevention of Acute Radiation Dermatitis with Topical Therapies. International Journal of Radiation Oncology*Biology*Physics. 120(2). e315–e315.
2.
Sjöström, Martin, Anthony Fyles, Fei‐Fei Liu, et al.. (2023). Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer. Journal of Clinical Oncology. 41(8). 1533–1540. 21 indexed citations
3.
Michmerhuizen, Anna R., Rachel Schwartz, Kari Wilder-Romans, et al.. (2022). Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer. British Journal of Cancer. 127(5). 927–936. 4 indexed citations
4.
Ligibel, Jennifer A., Lori J. Pierce, Catherine M. Bender, et al.. (2022). Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey. Cancer. 128(14). 2817–2825. 28 indexed citations
5.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2022). Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression. Cancer Research Communications. 2(7). 679–693. 7 indexed citations
6.
Michmerhuizen, Anna R., Rachel Schwartz, Kari Wilder-Romans, et al.. (2022). Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. npj Breast Cancer. 8(1). 31–31. 14 indexed citations
7.
Michmerhuizen, Anna R., Kari Wilder-Romans, Benjamin C. Chandler, et al.. (2021). RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes. JCI Insight. 7(3). 21 indexed citations
8.
Puttonen, Henri, Martin Sjöström, Erik Holmberg, et al.. (2020). Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial. Clinical Cancer Research. 27(3). 749–758. 17 indexed citations
9.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2020). Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers. Clinical Cancer Research. 26(24). 6568–6580. 35 indexed citations
10.
Michmerhuizen, Anna R., Daniel E. Spratt, Lori J. Pierce, & Corey Speers. (2020). ARe we there yet? Understanding androgen receptor signaling in breast cancer. npj Breast Cancer. 6(1). 47–47. 76 indexed citations
11.
Michmerhuizen, Anna R., Benjamin C. Chandler, Kari Wilder-Romans, et al.. (2019). PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation. Molecular Cancer Therapeutics. 18(11). 2063–2073. 41 indexed citations
12.
Sjöström, Martin, S. Laura Chang, Nick Fishbane, et al.. (2019). Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy. Clinical Cancer Research. 26(1). 171–182. 12 indexed citations
13.
Dess, Robert T., Yilun Sun, Daniel G. Muenz, et al.. (2019). Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium. Practical Radiation Oncology. 10(1). e27–e36. 13 indexed citations
14.
Matuszak, M.M., Maria C. Mejia de Grubb, Robin Marsh, et al.. (2018). Knowledge Based Quality Assurance and Improvement in Locally Advanced Lung Cancer Radiation Therapy in a Statewide Consortium of Academic and Community Practice Centers. International Journal of Radiation Oncology*Biology*Physics. 102(3). S217–S217. 1 indexed citations
15.
Speers, Corey, Shuang Zhao, Meilan Liu, et al.. (2015). Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. Clinical Cancer Research. 21(16). 3667–3677. 114 indexed citations
16.
Woodward, Wendy A., Nour Sneige, Kathryn Winter, et al.. (2014). Web based pathology assessment in RTOG 98-04. Journal of Clinical Pathology. 67(9). 777–780. 3 indexed citations
17.
Halyard, Michele Y., Thomas M. Pisansky, Amylou C. Dueck, et al.. (2009). Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831. Journal of Clinical Oncology. 27(16). 2638–2644. 127 indexed citations
18.
Pierce, Lori J., Bruce G. Haffty, Lawrence J. Solin, et al.. (1997). The conservative management of Paget's disease of the breast with radiotherapy. Cancer. 80(6). 1065–1072. 48 indexed citations
19.
Pierce, Lori J., Bruce G. Haffty, Lawrence J. Solin, et al.. (1997). The conservative management of Paget's disease of the breast with radiotherapy. Cancer. 80(6). 1065–1072. 1 indexed citations
20.
Pierce, Lori J. & Allen S. Lichter. (1996). Defining the role of post-mastectomy radiotherapy: the new evidence.. PubMed. 10(7). 991–7, 1011. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026